Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.59)
# 2,777
Out of 4,339 analysts
98
Total ratings
36.5%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AIM: AMS Advanced Medical Solutions Group plc | Maintained: Buy | 245p | $212.50 | +15.29% | 12 | May 21, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | $201.20 | +56.56% | 10 | Mar 11, 2026 | |
| PLLWF Polarean Imaging plc | Maintained: Buy | $0.11 → $0.05 | $0.0066 | +717.03% | 9 | Sep 25, 2025 | |
| AIM: DXRX Diaceutics PLC | Maintained: Buy | 225p | $151.00 | +49.01% | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Maintained: Buy | 29p → 35p | $27.40 | +27.74% | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Maintained: Hold | 1,850p → 2,300p | $2,462.00 | -6.58% | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | $1,480.00 | n/a | 8 | Apr 24, 2025 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 397p → 410p | $395.00 | n/a | 5 | Mar 21, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Reiterated: Buy | €4.00 | $0.89600003 | n/a | 3 | Nov 19, 2024 | |
| AMS: PHARM Pharming Group N.V. | Reiterated: Buy | n/a | $1.19 | n/a | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 105p | $77.60 | n/a | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €109.00 | $100.80 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €225.95 → €243.99 | $24.60 | n/a | 9 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,451p → 4,080p | $9.10 | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 7,047p → 5,563p | $51.00 | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,429p → 13,946p | $66.80 | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 12,981p | $0.1785 | n/a | 3 | May 18, 2017 |
Advanced Medical Solutions Group plc
May 21, 2026
Maintained: Buy
Price Target: 245p
Current: $212.50
Upside: +15.29%
Convatec Group PLC
Mar 11, 2026
Reiterated: Buy
Price Target: 315p
Current: $201.20
Upside: +56.56%
Polarean Imaging plc
Sep 25, 2025
Maintained: Buy
Price Target: $0.11 → $0.05
Current: $0.0066
Upside: +717.03%
Diaceutics PLC
Sep 23, 2025
Maintained: Buy
Price Target: 225p
Current: $151.00
Upside: +49.01%
EKF Diagnostics Holdings plc
Sep 16, 2025
Maintained: Buy
Price Target: 29p → 35p
Current: $27.40
Upside: +27.74%
Genus plc
Sep 9, 2025
Maintained: Hold
Price Target: 1,850p → 2,300p
Current: $2,462.00
Upside: -6.58%
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: $1,480.00
Upside: n/a
Uniphar plc
Mar 21, 2025
Reiterated: Buy
Price Target: 397p → 410p
Current: $395.00
Upside: n/a
Nanoform Finland Oyj
Nov 19, 2024
Reiterated: Buy
Price Target: €4.00
Current: $0.89600003
Upside: n/a
Pharming Group N.V.
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.19
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: 105p
Current: $77.60
Upside: n/a
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: $100.80
Upside: n/a
Nov 12, 2018
Reiterated: Buy
Price Target: €225.95 → €243.99
Current: $24.60
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,451p → 4,080p
Current: $9.10
Upside: n/a
May 24, 2018
Maintained: Buy
Price Target: 7,047p → 5,563p
Current: $51.00
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,429p → 13,946p
Current: $66.80
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 12,981p
Current: $0.1785
Upside: n/a